Seguir
Maria Kamusheva
Maria Kamusheva
Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, MU-Sofia
Dirección de correo verificada de pharmfac.mu-sofia.bg
Título
Citado por
Citado por
Año
Assessment of the expectancy, seriousness and severity of adverse drug reactions reported for chronic obstructive pulmonary disease therapy
G Petrova, A Stoimenova, M Dimitrova, M Kamusheva, D Petrova, ...
SAGE open medicine 5, 2050312117690404, 2017
552017
Life expectancy and survival analysis of patients with diabetes compared to the non diabetic population in Bulgaria
K Tachkov, K Mitov, Y Koleva, Z Mitkova, M Kamusheva, M Dimitrova, ...
PloS one 15 (5), e0232815, 2020
512020
Proposal for a regulation on health technology assessment in Europe–opinions of policy makers, payers and academics from the field of HTA
P Vella Bonanno, A Bucsics, S Simoens, AP Martin, W Oortwijn, ...
Expert review of pharmacoeconomics & outcomes research 19 (3), 251-261, 2019
512019
The Potential Role of the Pharmacist in Supporting Patients with Depression – A Literature-Based Point of View.
M Kamusheva, D Ignatova, A Golda, A Skowron
Integr Pharm Res Pract. 9, 49-63, 2020
492020
The European challenges of funding orphan medicinal products
M Szegedi, T Zelei, F Arickx, A Bucsics, E Cohn-Zanchetta, J Fürst, ...
Orphanet journal of rare diseases 13, 1-8, 2018
432018
Comparative price analysis of biological products for treatment of rheumatoid arthritis
M Manova, A Savova, M Vasileva, S Terezova, M Kamusheva, D Grekova, ...
Frontiers in Pharmacology 9, 1070, 2018
402018
Quality of life and cost study of rheumatoid arthritis therapy with biological medicines
VV Boyadzieva, N Stoilov, RM Stoilov, K Tachkov, M Kamusheva, K Mitov, ...
Frontiers in pharmacology 9, 794, 2018
342018
Evaluation of the economic and social burden of chronic obstructive pulmonary disease (COPD)
K Tachkov, M Kamusheva, V Pencheva, K Mitov
Biotechnology & Biotechnological Equipment 31 (4), 855-861, 2017
322017
Barriers to use artificial intelligence methodologies in health technology assessment in central and east European countries
K Tachkov, A Zemplenyi, M Kamusheva, M Dimitrova, P Siirtola, J Pontén, ...
Frontiers in Public Health 10, 921226, 2022
262022
Influence of COVID-19 on Health-Related Quality of Life and the Perception of Being Vaccinated to Prevent COVID-19: An Approach for Community Pharmacists from Romania and Bulgaria
A Turcu-Stiolica, M Bogdan, MS Subtirelu, AD Meca, AE Tae- rel, I Iaru, ...
J. Clin. Med., 864, 2021
252021
Clinical characteristics, treatment patterns, and socio-economic burden of COPD in Bulgaria
M Kamusheva, M Dimitrova, JFM van Boven, MJ Postma, T van der Molen, ...
Journal of medical economics 20 (5), 503-509, 2017
242017
New Epidemiological, Clinical and Economic Data for Patients With Acromegaly in Bulgaria
M Kamusheva, S Vandeva, K Mitov, Y Rusenova, A Elenkova, ...
Frontiers in Public Health 8 (147), 2020
212020
A systematic review of collective evidences investigating the effect of diabetes monitoring systems and their application in health care
M Kamusheva, K Tachkov, M Dimitrova, Z Mitkova, G García-Sáez, ...
Frontiers in endocrinology 12, 636959, 2021
182021
Comparative analysis of legislative requirements about patients' access to biotechnological drugs for rare diseases in Central and Eastern European Countries
M Kamusheva, M Manova, AT Savova, GI Petrova, K Mitov, A Harsányi, ...
Frontiers in pharmacology 9, 795, 2018
182018
Pharmacist's perspectives on administering a COVID-19 vaccine in community pharmacies in four balkan countries
A Turcu-Stiolica, M Kamusheva, M Bogdan, I Tadic, K Harasani, ...
Frontiers in Public Health 9, 766146, 2021
172021
Orphan medicinal products’ access to the Bulgarian pharmaceutical market – challenges and obstacles
ASMM Maria Kamusheva, Konstantin Tachkov, Guenka Petrova
EXPERT OPINION ON ORPHAN DRUGS, 2017
16*2017
A cross-country comparison of reimbursed orphan medicines in Bulgaria, Greece and Romania
M Kamusheva, A Stoimenova, M Doneva, A Zlatareva, G Petrova
Biotechnology & Biotechnological Equipment 27 (5), 4186-4192, 2013
142013
Chronic obstructive pulmonary disease exacerbations and progression in relation to ambient air pollutants exposure
M Doneva, G Petrova, D Petrova, M Kamusheva, V Petkova, K Tachkov, ...
Journal of Thoracic Disease 11 (6), 2490, 2019
122019
Burden of informal care for individuals with schizophrenia and affective disorders prior to hospital admission
GO D. Ignatova, M. Kamusheva, G. Petrova
European Journal of Psychiatry, 2018
12*2018
Do advanced therapies have a future in the low-and middle-income countries - the case with Bulgaria, Romania and Poland
M Kamusheva, A Turcu-Stiolica, J Gierczyński, MS Subtirelu, M Czech, ...
Front. Public Health 9 (729847), 2021
112021
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20